Cross Sectional CFAR HIV/COVID-19 Study

University of Miami64 enrolled

Overview

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Study Type

OBSERVATIONAL

Enrollment

Conditions

SARS-CoV Infection Covid19

Eligibility

Sex: ALLMin age: 3 YearsMax age: 25 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI) * Being diagnosed with HIV infection by the time of enrollment * At enrollment, 3 to \< 26 years Exclusion Criteria: * Patient will be excluded from the study if any of the following are identified: * Patients under legal age and in the State's custody * Participant or legal guardian unable to sign Informed Consent forms * Participant unable to complete study visits

Locations (1)

Batchelor's Children's Research Institute

Miami, Florida, United States

Outcomes

Primary Outcomes

Number of participants who tested positive with SARS COV-2 Infection

SARS COV-2 Infection will be analyzed from nasopharyngeal swab samples via RT-PCR assay

Time frame: month 3

Number of participants who tested positive with SARS COV-2 antibody

SARS COV-2 antibody will be analyzed from blood samples via serological assay

Time frame: month 3

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.